Ikena Oncology Inc.
13F holders, Q1 2025 (March 31)At the end of Q1 2025, 46 institutions reported holding Ikena Oncology Inc. in their 13F filings, down 7 from Q4 2024. 3 opened new positions and 10 sold out. The largest holders were Atlas Venture Life Science Advisors, LLC ($6.4M), Blue Owl Capital Holdings LP ($5.2M) and BVF Inc. ($5.1M). 3 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Ikena Oncology Inc.
- CUSIP
- 45175G108
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $3.5M |
| Exits | 10 | $375K |
All 13F filers, Q4 2024 → Q1 2025: 3,033,044 shares bought and 1,996,279 shares sold, net +1,036,765 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 46 holders
| Atlas Venture Life Science Advisors, LLC | 1.23% | No change | 5,018,178 | $6.4M |
| Blue Owl Capital Holdings LP | 1.69% | No change | 4,091,118 | $5.2M |
| BVF Inc. | 0.21% | No change | 4,006,564 | $5.1M |
| BML Capital Management, LLC | 3.84% | Add +3.5% | 3,710,803 | $4.7M |
| Orbimed Advisors LLC | 0.11% | No change | 3,539,358 | $4.5M |
| Deep Track Capital, LP | 0.10% | New | 2,515,513 | $3.2M |
| Omega Fund Management, LLC | 1.70% | No change | 2,249,123 | $2.9M |
| Vanguard Group Inc. | 0.00% | Reduce -0.1% | 1,383,418 | $1.8M |
| Gilead Sciences, Inc. | 0.13% | Reduce -42.3% | 1,159,145 | $1.5M |
| Adage Capital Partners Gp, L.L.C. | 0.00% | No change | 800,000 | $1.0M |
| NEA Management Company, LLC | 0.06% | No change | 600,063 | $768K |
| Sofinnova Investments, Inc. | 0.04% | No change | 382,616 | $490K |
| BlackRock, Inc. | 0.00% | Reduce -1.0% | 348,634 | $446K |
| Geode Capital Management, LLC | 0.00% | Reduce -3.3% | 317,091 | $406K |
| Peapod Lane Capital LLC | 0.43% | Reduce -41.6% | 296,437 | $379K |
| Renaissance Technologies | 0.00% | Reduce -10.8% | 294,487 | $377K |
| Aldebaran Capital, LLC | 0.30% | New | 247,795 | $317K |
| Jacobs Levy Equity Management, Inc. | 0.00% | Reduce -25.0% | 245,485 | $314K |
| Acadian Asset Management LLC | 0.00% | Reduce -27.3% | 209,568 | $266K |
| Bridgeway Capital Management, LLC | 0.00% | Reduce -0.3% | 153,300 | $196K |
| Two Sigma Advisers, LP | 0.00% | Reduce -3.8% | 151,400 | $194K |
| UBS Group AG | 0.00% | Add +40.1% | 100,660 | $129K |
| State Street Corp. | 0.00% | No change | 92,153 | $118K |
| Deuterium Capital Management, LLC | 0.23% | No change | 80,579 | $103K |
| Citadel Advisors | 0.00% | Reduce -0.8% | 79,687 | $102K |
| Two Sigma Investments, LP | 0.00% | Reduce -21.2% | 79,422 | $102K |
| Squarepoint Ops LLC | 0.00% | Add +77.4% | 77,434 | $99K |
| Goldman Sachs Group Inc. | 0.00% | Add +62.4% | 76,464 | $98K |
| BBR Partners, LLC | 0.01% | No change | 70,000 | $90K |
| Millennium Management | 0.00% | Reduce -65.1% | 69,684 | $89K |
| Barclays PLC | 0.00% | Reduce -66.1% | 66,177 | $85K |
| Northern Trust Corp. | 0.00% | No change | 57,565 | $74K |
| XTX Topco Ltd | 0.00% | Add +350.6% | 56,452 | $72K |
| Dimensional Fund Advisors LP | 0.00% | No change | 38,621 | $50K |
| Prudential Financial Inc. | 0.00% | Add +42.9% | 26,000 | $33K |
| Vanguard Personalized Indexing Management, LLC | 0.00% | Add +3.6% | 16,952 | $22K |
| Berkshire Asset Management LLC | 0.00% | No change | 20,000 | $22K |
| Morgan Stanley | 0.00% | Reduce -18.4% | 12,571 | $16K |
| FMR LLC | 0.00% | Reduce -52.2% | 5,063 | $6K |
| JPMorgan Chase & Co. | 0.00% | Reduce -99.5% | 849 | $1K |
| Coldstream Capital Management Inc. | 0.00% | New | 525 | $672 |
| BNP Paribas Financial Markets | 0.00% | Reduce -99.3% | 315 | $403 |
| Bank of America Corp. | 0.00% | Reduce -11.9% | 221 | $283 |
| Farther Finance Advisors, LLC | 0.00% | No change | 108 | $135 |
| Nisa Investment Advisors, LLC | 0.00% | Reduce -30.3% | 69 | $88 |
| SBI Securities Co., Ltd. | 0.00% | No change | 3 | $4 |
"% of holder's portfolio" is IKENA ONCOLOGY INC's weight in each manager's 13F, not the share of Ikena Oncology Inc. the manager owns.